This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Cornelia Dorner-Clossek: Innovator in Amyloid Research
Introduction
Cornelia Dorner-Clossek is a notable inventor based in Ravensburg, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of diseases associated with amyloid beta peptides. Her innovative work has led to the development of a patented method that addresses critical health issues.
Latest Patents
Cornelia Dorner-Clossek holds a patent for a method of treating diseases and conditions associated with an altered level of amyloid beta peptides. This patent, which is focused on a method of treating or preventing diseases related to increased levels of isoforms of amyloid beta peptides, showcases her expertise in biochemistry and pharmacology. The patent details a therapeutic approach involving the administration of specific enolcarboxamide compounds to mammals.
Career Highlights
Throughout her career, Dorner-Clossek has been associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her work has been instrumental in advancing the understanding of amyloid-related conditions, contributing to the development of effective treatments. With her innovative mindset, she continues to push the boundaries of medical research.
Collaborations
Cornelia has collaborated with esteemed colleagues, including Klaus Bornemann and Guenter Trummlitz. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.
Conclusion
Cornelia Dorner-Clossek is a pioneering inventor whose work in amyloid research has the potential to transform treatment options for various diseases. Her contributions to the field are invaluable, and her patented methods represent a significant advancement in medical science.